Overview: Biomet is facing yet another lawsuit from a hip implant recipient who says that their M2a Magnum™ hip implant caused serious injuries. Parker Waichman LLP, a national personal injury firm, filed the suit on November 20th in the U.S. District Court of New Jersey. Biomet, Inc. and Biomet Orthopaedics, LLC are named as Defendants in the case. Among other things, the lawsuit alleges that the M2a Magnum is defective because it is a metal-on-metal hip implant, a class of medical devices have been under increasing scrutiny due to their associated with high failure rates.
- Parker Waichman LLP has filed a lawsuit on behalf of a New Jersey man who received the Biomet M2a Magnum hip system
- The lawsuit alleges that the all-metal hip replacement caused the Plaintiff to suffer severe pain, high levels of chromium and cobalt ions, and other damages
- Metal-on-metal hip implants are associated with a high rate of failure compared to other types of implants; researchers have found that the devices can lead to elevated metal ion levels because the design forces metal to rub against metal, shedding particles into the bloodstream and local tissue
Product: M2a Magnum™ Hip System
Manufacturer: Biomet Orthopaedics
Side Effects & Complications
- High failure rate
- Necrosis (tissue death)
- Increased levels of cobalt and chromium ions
- Pain at the implant, sometimes spreading to the groin and back
- Osteolysis (bone loss)
- Fluid collections/solid masses around the hip joint
Biomet Hip Implant is Faulty, Lawsuit States
The Biomet M2a Magnum hip system was implanted in the Plaintiff’s left hip. According to a press release by Parker Waichman, the implant failed and caused the Plaintiff to suffer severe pain, instability and elevated chromium and cobalt levels. Following these complications, the Plaintiff underwent a revision surgery to remove the implant. The lawsuit is suing for a number of damages suffered by the Plaintiff as an alleged result of the implant, including severe and possibly permanent injuries, pain, suffering, emotional distress and economic loss.
The lawsuit also alleges that the Defendants did not adequately warn the Plaintiff about the risks of using the Biomet M2a Magnum, even though the U.S. Food and Drug Administration (FDA) had received over 100 reports of adverse events related to the metal-on-metal hip replacement at the time he received the implant.
Metal-on-Metal Hips Notorious for High Failure Rates
The Biomet M2a Magnum is a metal-on-metal hip implant, meaning that the device involves all-metal surfaces. All-metal hip replacements have become a subject of safety concerns in the orthopedic community because they have become increasingly associated with high failure rates. As the lawsuit points out, metal-on-metal hip implants such as the Biomet M2a Magnum release metal ions into the blood because the design forces metal to rub against metal with the full weight of the body. An excessive amount of metal ions released in the bloodstream or seeped into nearby tissues may lead to painful and serious complications, such as soft tissue reaction, pseudotumors, bone damage and the need for revision surgery.